Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Circulating endothelial cells as biomarkers for patients receiving bevacizumab.

× No keyword cloud information.

3 in total

1. Phase II study of bevacizumab, cisplatin, and docetaxel plus maintenance bevacizumab as first-line treatment for patients with advanced non-squamous non-small-cell lung cancer combined with exploratory analysis of circulating endothelial cells: Thoracic Oncology Research Group (TORG)1016.

Authors: Satoshi Ikeda; Terufumi Kato; Takashi Ogura; Akimasa Sekine; Tsuneyuki Oda; Noriyuki Masuda; Satoshi Igawa; Ken Katono; Sakiko Otani; Kouzo Yamada; Haruhiro Saito; Tetsuro Kondo; Yukio Hosomi; Yoshiro Nakahara; Masanori Nishikawa; Keiko Utumi; Yuki Misumi; Takeharu Yamanaka; Kentaro Sakamaki; Hiroaki Okamoto
Journal: BMC Cancer Date: 2018-03-02 Impact factor: 4.430

2. Levels of a subpopulation of platelets, but not circulating endothelial cells, predict early treatment failure in prostate cancer patients after prostatectomy.

Authors: C K E Wong; B Namdarian; J Chua; X Chin; R Speirs; T Nguyen; M Fankhauser; J Pedersen; A J Costello; N M Corcoran; C M Hovens
Journal: Br J Cancer Date: 2012-10-09 Impact factor: 7.640

3. Prognostic value of CD109+ circulating endothelial cells in recurrent glioblastomas treated with bevacizumab and irinotecan.

Authors: Lucia Cuppini; Angelica Calleri; Maria Grazia Bruzzone; Elena Prodi; Elena Anghileri; Serena Pellegatta; Patrizia Mancuso; Paola Porrati; Anna Luisa Di Stefano; Mauro Ceroni; Francesco Bertolini; Gaetano Finocchiaro; Marica Eoli
Journal: PLoS One Date: 2013-09-12 Impact factor: 3.240

3 in total